Norma Bloy

4.0k total citations
39 papers, 1.5k citations indexed

About

Norma Bloy is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Norma Bloy has authored 39 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 22 papers in Immunology and 15 papers in Molecular Biology. Recurrent topics in Norma Bloy's work include Immunotherapy and Immune Responses (14 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Immune Cell Function and Interaction (7 papers). Norma Bloy is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Immune Cell Function and Interaction (7 papers). Norma Bloy collaborates with scholars based in France, United States and Spain. Norma Bloy's co-authors include Lorenzo Galluzzi, Aitziber Buqué, Guido Kroemer, Laurence Zitvogel, Alexander Eggermont, Jérôme Galon, Isabelle Cremer, Jitka Fučíková, Radek Špíšek and Fernando Aranda and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature Immunology.

In The Last Decade

Norma Bloy

36 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norma Bloy France 19 841 776 483 185 143 39 1.5k
Osamu Shimozato Japan 23 927 1.1× 680 0.9× 500 1.0× 214 1.2× 92 0.6× 61 1.6k
Jean-Pierre Abastado France 15 875 1.0× 718 0.9× 419 0.9× 109 0.6× 84 0.6× 19 1.4k
Meng Wu China 12 463 0.6× 513 0.7× 485 1.0× 130 0.7× 61 0.4× 31 1.2k
Thomas Bukur Germany 12 751 0.9× 445 0.6× 646 1.3× 124 0.7× 90 0.6× 21 1.4k
Helena Harlin United States 16 1.6k 1.9× 1.3k 1.7× 742 1.5× 145 0.8× 125 0.9× 25 2.4k
Duygu Sari United States 10 854 1.0× 641 0.8× 459 1.0× 87 0.5× 114 0.8× 22 1.4k
Tetsuro Sasada Japan 18 1.2k 1.4× 800 1.0× 434 0.9× 63 0.3× 79 0.6× 49 1.7k
Justin M. David United States 18 558 0.7× 769 1.0× 543 1.1× 66 0.4× 60 0.4× 30 1.4k
Jennifer N. Durham United States 18 400 0.5× 649 0.8× 379 0.8× 139 0.8× 127 0.9× 53 1.2k
Christopher E. Touloukian United States 16 1.5k 1.8× 838 1.1× 547 1.1× 155 0.8× 65 0.5× 23 1.8k

Countries citing papers authored by Norma Bloy

Since Specialization
Citations

This map shows the geographic impact of Norma Bloy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norma Bloy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norma Bloy more than expected).

Fields of papers citing papers by Norma Bloy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norma Bloy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norma Bloy. The network helps show where Norma Bloy may publish in the future.

Co-authorship network of co-authors of Norma Bloy

This figure shows the co-authorship network connecting the top 25 collaborators of Norma Bloy. A scholar is included among the top collaborators of Norma Bloy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norma Bloy. Norma Bloy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sato, Ai, Norma Bloy, Peng Liu, et al.. (2024). Flow cytometry-assisted analysis of phenotypic maturation markers on an immortalized dendritic cell line. Methods in cell biology. 189. 153–168.
2.
Charpentier, Maud, Norma Bloy, Silvia C. Formenti, Lorenzo Galluzzi, & Sandra Demaria. (2024). Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids. Journal of Visualized Experiments. 1 indexed citations
3.
Martinez, Aitziber Buqué, et al.. (2023). 1440 Shaping the immunometabolism of HR+ breast cancer with kynurenamines. SHILAP Revista de lepidopterología. A1603–A1603. 1 indexed citations
4.
Jiménez‐Cortegana, Carlos, Vanessa Klapp, Norma Bloy, et al.. (2022). Cytofluorometric assessment of cell cycle progression in irradiated cells. Methods in cell biology. 172. 1–16. 1 indexed citations
5.
Klapp, Vanessa, Norma Bloy, Giulia Petroni, & Mara De Martino. (2022). Quantification of beta-galactosidase activity as a marker of radiation-driven cellular senescence. Methods in cell biology. 174. 113–126. 1 indexed citations
6.
Bloy, Norma, Claudia Galassi, Ai Sato, et al.. (2022). Cytofluorometric assessment of acute cell death responses driven by radiation therapy. Methods in cell biology. 172. 17–36. 1 indexed citations
7.
Petroni, Giulia, Aitziber Buqué, Takahiro Yamazaki, et al.. (2021). Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer. Clinical Cancer Research. 27(7). 1855–1863. 36 indexed citations
8.
Sato, Ai, Aitziber Buqué, Takahiro Yamazaki, et al.. (2021). Immunofluorescence microscopy-based assessment of cytosolic DNA accumulation in mammalian cells. STAR Protocols. 2(2). 100488–100488. 8 indexed citations
9.
Yamazaki, Takahiro, Alexander Kirchmair, Ai Sato, et al.. (2020). Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy. Nature Immunology. 21(10). 1160–1171. 234 indexed citations
10.
Baracco, Elisa Elena, Federico Pietrocola, Aitziber Buqué, et al.. (2016). Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer. OncoImmunology. 5(6). e1139275–e1139275. 18 indexed citations
11.
Senovilla, Laura, Yohann Demont, Juliette Humeau, Norma Bloy, & Guido Kroemer. (2016). Image Cytofluorometry for the Quantification of Ploidy and Endoplasmic Reticulum Stress in Cancer Cells. Methods in molecular biology. 1524. 53–64. 7 indexed citations
12.
Vacchelli, Erika, Norma Bloy, Fernando Aranda, et al.. (2016). Trial Watch: Immunotherapy plus radiation therapy for oncological indications. OncoImmunology. 5(9). e1214790–e1214790. 67 indexed citations
13.
Bloy, Norma, Aitziber Buqué, Fernando Aranda, et al.. (2015). Trial watch: Naked and vectored DNA-based anticancer vaccines. OncoImmunology. 4(5). e1026531–e1026531. 32 indexed citations
14.
Vacchelli, Erika, Jonathan Pol, Norma Bloy, et al.. (2015). Trial watch: Tumor-targeting monoclonal antibodies for oncological indications. OncoImmunology. 4(1). e985940–e985940. 40 indexed citations
15.
Vacchelli, Erika, Fernando Aranda, Norma Bloy, et al.. (2015). Trial Watch—Immunostimulation with cytokines in cancer therapy. OncoImmunology. 5(2). e1115942–e1115942. 44 indexed citations
16.
Kepp, Oliver, Michaëla Semeraro, José Manuel Bravo‐San Pedro, et al.. (2015). eIF2α phosphorylation as a biomarker of immunogenic cell death. Seminars in Cancer Biology. 33. 86–92. 95 indexed citations
17.
Iribarren, Kristina, Norma Bloy, Aitziber Buqué, et al.. (2015). Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy. OncoImmunology. 5(3). e1088631–e1088631. 108 indexed citations
18.
Pol, Jonathan, Aitziber Buqué, Fernando Aranda, et al.. (2015). Trial Watch—Oncolytic viruses and cancer therapy. OncoImmunology. 5(2). e1117740–e1117740. 92 indexed citations
19.
Bloy, Norma, Jonathan Pol, Gwenola Manic, et al.. (2014). Trial Watch: Radioimmunotherapy for oncological indications. OncoImmunology. 3(9). e954929–e954929. 47 indexed citations
20.
Aranda, Fernando, Norma Bloy, Lorenzo Galluzzi, Guido Kroemer, & Laura Senovilla. (2014). Vitamin B6 improves the immunogenicity of cisplatin-induced cell death. OncoImmunology. 3(9). e955685–e955685. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Osamu Shimozato Breakdown of academic impact, for papers by Jean-Pierre Abastado Breakdown of academic impact, for papers by Meng Wu Breakdown of academic impact, for papers by Thomas Bukur Breakdown of academic impact, for papers by Helena Harlin Breakdown of academic impact, for papers by Duygu Sari Breakdown of academic impact, for papers by Tetsuro Sasada Breakdown of academic impact, for papers by Justin M. David Breakdown of academic impact, for papers by Jennifer N. Durham Breakdown of academic impact, for papers by Christopher E. Touloukian
Rankless by CCL
2026